 Michael Alberti
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Splicing Factor U2AF | 3 | 2026 | 18 | 1.310 |
Why?
| | Myelodysplastic Syndromes | 2 | 2026 | 147 | 0.990 |
Why?
| | Abiotrophia | 2 | 2016 | 2 | 0.960 |
Why?
| | Carnobacteriaceae | 2 | 2016 | 3 | 0.960 |
Why?
| | Hematopoiesis | 1 | 2026 | 194 | 0.870 |
Why?
| | Genotyping Techniques | 1 | 2024 | 69 | 0.830 |
Why?
| | Leukocyte Common Antigens | 1 | 2024 | 88 | 0.830 |
Why?
| | Mutation | 4 | 2026 | 4099 | 0.730 |
Why?
| | Adenoviridae | 2 | 2012 | 199 | 0.700 |
Why?
| | Myeloid Cells | 2 | 2012 | 148 | 0.680 |
Why?
| | Genetic Therapy | 2 | 2012 | 313 | 0.630 |
Why?
| | Hematologic Neoplasms | 2 | 2021 | 162 | 0.630 |
Why?
| | Myeloproliferative Disorders | 1 | 2018 | 19 | 0.560 |
Why?
| | Gene Duplication | 1 | 2018 | 67 | 0.550 |
Why?
| | Genetic Vectors | 3 | 2014 | 337 | 0.510 |
Why?
| | Disk Diffusion Antimicrobial Tests | 1 | 2016 | 1 | 0.490 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2147 | 0.490 |
Why?
| | Mice, Inbred C57BL | 4 | 2024 | 5997 | 0.460 |
Why?
| | Luciferases, Renilla | 1 | 2015 | 4 | 0.460 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 19 | 0.460 |
Why?
| | Internal Ribosome Entry Sites | 1 | 2015 | 6 | 0.450 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1915 | 0.450 |
Why?
| | Repressor Proteins | 1 | 2018 | 437 | 0.440 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 550 | 0.430 |
Why?
| | Virus Replication | 3 | 2015 | 529 | 0.430 |
Why?
| | Mycophenolic Acid | 1 | 2014 | 120 | 0.410 |
Why?
| | Viral Tropism | 1 | 2012 | 36 | 0.380 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2014 | 598 | 0.370 |
Why?
| | Gene Transfer Techniques | 2 | 2014 | 185 | 0.360 |
Why?
| | Protein Biosynthesis | 1 | 2015 | 458 | 0.360 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1322 | 0.340 |
Why?
| | Drug Monitoring | 1 | 2014 | 395 | 0.330 |
Why?
| | Alleles | 2 | 2024 | 881 | 0.310 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1786 | 0.290 |
Why?
| | HIV-1 | 1 | 2015 | 896 | 0.290 |
Why?
| | Neoplasm Proteins | 2 | 2021 | 444 | 0.280 |
Why?
| | Peptide Fragments | 1 | 2012 | 699 | 0.270 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2026 | 19 | 0.240 |
Why?
| | Mice | 10 | 2026 | 18365 | 0.240 |
Why?
| | RNA Splicing Factors | 1 | 2026 | 65 | 0.240 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2026 | 27 | 0.230 |
Why?
| | Specimen Handling | 2 | 2019 | 186 | 0.230 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2026 | 683 | 0.230 |
Why?
| | Flow Cytometry | 2 | 2024 | 1173 | 0.230 |
Why?
| | RNA, Long Noncoding | 2 | 2017 | 178 | 0.210 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 10 | 0.200 |
Why?
| | DNA Damage | 1 | 2026 | 430 | 0.200 |
Why?
| | B-Lymphocytes | 3 | 2021 | 877 | 0.180 |
Why?
| | Hepacivirus | 3 | 2010 | 243 | 0.180 |
Why?
| | Lymphopoiesis | 1 | 2021 | 27 | 0.170 |
Why?
| | Genes, Reporter | 3 | 2021 | 276 | 0.170 |
Why?
| | Genotype | 3 | 2024 | 1835 | 0.170 |
Why?
| | Animals | 10 | 2026 | 38109 | 0.170 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 264 | 0.170 |
Why?
| | Polymerase Chain Reaction | 1 | 2024 | 1054 | 0.170 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 173 | 0.160 |
Why?
| | Heterozygote | 1 | 2021 | 315 | 0.160 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 72 | 0.160 |
Why?
| | Immunosuppressive Agents | 2 | 2016 | 847 | 0.160 |
Why?
| | Inflammation | 1 | 2012 | 2880 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 86 | 0.160 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 293 | 0.160 |
Why?
| | CRISPR-Cas Systems | 1 | 2021 | 170 | 0.150 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2021 | 211 | 0.150 |
Why?
| | Leukemia | 1 | 2021 | 245 | 0.150 |
Why?
| | Alternative Splicing | 1 | 2021 | 249 | 0.150 |
Why?
| | Humans | 20 | 2026 | 144957 | 0.140 |
Why?
| | 5' Untranslated Regions | 2 | 2010 | 59 | 0.140 |
Why?
| | Biological Specimen Banks | 1 | 2019 | 103 | 0.130 |
Why?
| | Nucleic Acids | 1 | 2019 | 72 | 0.130 |
Why?
| | SOXC Transcription Factors | 1 | 2017 | 9 | 0.130 |
Why?
| | Artifacts | 1 | 2018 | 139 | 0.130 |
Why?
| | Phenotype | 1 | 2026 | 3164 | 0.130 |
Why?
| | Pregnancy Complications | 1 | 2023 | 592 | 0.130 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2018 | 104 | 0.130 |
Why?
| | K562 Cells | 3 | 2026 | 93 | 0.130 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 30 | 0.130 |
Why?
| | Molecular Typing | 1 | 2015 | 21 | 0.120 |
Why?
| | Culture Media | 1 | 2016 | 161 | 0.120 |
Why?
| | Transduction, Genetic | 2 | 2014 | 133 | 0.120 |
Why?
| | Immunoassay | 1 | 2016 | 109 | 0.120 |
Why?
| | Histones | 1 | 2021 | 670 | 0.120 |
Why?
| | Los Angeles | 1 | 2015 | 76 | 0.120 |
Why?
| | beta-Lactams | 1 | 2015 | 32 | 0.120 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 143 | 0.110 |
Why?
| | Tacrolimus | 1 | 2016 | 196 | 0.110 |
Why?
| | HEK293 Cells | 2 | 2021 | 744 | 0.110 |
Why?
| | O(6)-Methylguanine-DNA Methyltransferase | 1 | 2014 | 6 | 0.110 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2015 | 70 | 0.110 |
Why?
| | Lentivirus | 1 | 2014 | 60 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 2 | 2015 | 420 | 0.110 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 89 | 0.110 |
Why?
| | Blood Specimen Collection | 1 | 2014 | 38 | 0.110 |
Why?
| | Microbial Sensitivity Tests | 1 | 2015 | 371 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1495 | 0.100 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2015 | 202 | 0.100 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 559 | 0.100 |
Why?
| | Down-Regulation | 1 | 2015 | 627 | 0.100 |
Why?
| | Cell Line, Tumor | 4 | 2026 | 3550 | 0.090 |
Why?
| | Kupffer Cells | 1 | 2012 | 53 | 0.090 |
Why?
| | Prognosis | 2 | 2018 | 4293 | 0.090 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2012 | 157 | 0.090 |
Why?
| | Peptide Library | 1 | 2012 | 95 | 0.090 |
Why?
| | Hepatocytes | 1 | 2012 | 224 | 0.090 |
Why?
| | Bone Marrow Cells | 1 | 2012 | 320 | 0.080 |
Why?
| | Gene Expression | 1 | 2014 | 1490 | 0.080 |
Why?
| | Blotting, Western | 1 | 2012 | 1187 | 0.080 |
Why?
| | Translocation, Genetic | 2 | 2021 | 118 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 1129 | 0.070 |
Why?
| | Hepatitis C | 1 | 2010 | 254 | 0.070 |
Why?
| | Virus Cultivation | 1 | 2006 | 31 | 0.060 |
Why?
| | Cell Proliferation | 3 | 2021 | 2499 | 0.060 |
Why?
| | Endothelial Cells | 1 | 2012 | 870 | 0.060 |
Why?
| | Spliceosomes | 1 | 2026 | 53 | 0.060 |
Why?
| | Protein Binding | 1 | 2012 | 2276 | 0.060 |
Why?
| | Gene Deletion | 1 | 2006 | 389 | 0.050 |
Why?
| | Macrophages | 2 | 2010 | 1511 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2021 | 1258 | 0.050 |
Why?
| | Hepatitis C, Chronic | 1 | 2006 | 152 | 0.050 |
Why?
| | RNA Splicing | 1 | 2026 | 285 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2021 | 3125 | 0.050 |
Why?
| | Liver | 1 | 2012 | 1888 | 0.050 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2023 | 676 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1982 | 0.040 |
Why?
| | Tumor Stem Cell Assay | 1 | 2021 | 34 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2021 | 86 | 0.040 |
Why?
| | Genetic Variation | 1 | 2006 | 984 | 0.040 |
Why?
| | RNA, Neoplasm | 1 | 2021 | 86 | 0.040 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2021 | 56 | 0.040 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2021 | 92 | 0.040 |
Why?
| | Transgenes | 1 | 2021 | 190 | 0.040 |
Why?
| | Lung | 1 | 2012 | 4109 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2931 | 0.040 |
Why?
| | Tissue Fixation | 1 | 2019 | 37 | 0.040 |
Why?
| | Trans-Activators | 1 | 2021 | 405 | 0.040 |
Why?
| | Paraffin Embedding | 1 | 2019 | 33 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 803 | 0.040 |
Why?
| | Genetic Testing | 1 | 2021 | 482 | 0.030 |
Why?
| | Cell Cycle | 1 | 2021 | 597 | 0.030 |
Why?
| | Binding Sites | 1 | 2021 | 1331 | 0.030 |
Why?
| | YY1 Transcription Factor | 1 | 2017 | 25 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 640 | 0.030 |
Why?
| | Sp1 Transcription Factor | 1 | 2015 | 25 | 0.030 |
Why?
| | Gene Order | 1 | 2014 | 27 | 0.030 |
Why?
| | Base Sequence | 2 | 2010 | 2191 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 336 | 0.030 |
Why?
| | Gene Dosage | 1 | 2014 | 148 | 0.030 |
Why?
| | Phylogeny | 2 | 2010 | 1019 | 0.030 |
Why?
| | Fluorouracil | 1 | 2014 | 235 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3608 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2365 | 0.020 |
Why?
| | Cell Survival | 1 | 2015 | 1098 | 0.020 |
Why?
| | RNA | 1 | 2019 | 940 | 0.020 |
Why?
| | DNA | 1 | 2019 | 1464 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1990 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1462 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7191 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 368 | 0.020 |
Why?
| | Transcriptome | 1 | 2015 | 1046 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5233 | 0.020 |
Why?
| | RNA, Viral | 1 | 2006 | 688 | 0.010 |
Why?
| | Female | 2 | 2023 | 78376 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4155 | 0.010 |
Why?
| | United States | 1 | 2016 | 15988 | 0.010 |
Why?
| | Child | 1 | 2017 | 22657 | 0.010 |
Why?
| | Time Factors | 1 | 2006 | 7183 | 0.010 |
Why?
| | Middle Aged | 1 | 2006 | 35928 | 0.000 |
Why?
|
|
Alberti's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|